Melanoma Cell Adhesion Molecule (CD 146) in Endometrial Physiology and Disorder

review OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

This chapter examines melanoma cell adhesion molecule (MCAM/CD146/MUC18), a highly expressed endometrial membrane glycoprotein, focusing on its roles in normal endometrial regeneration and angiogenesis as well as in endometrial dysfunctions. It synthesizes existing evidence that CD146 can serve as a marker of angiogenic dysfunction and malignancy, including endometrial cancer, while noting that its mechanistic contribution to pathology remains unclear. A key limitation is that, as a chapter overview, it does not present new experimental data or define a single mechanistic pathway. Relevance to endometriosis: the paper explicitly states that endometriosis is among endometrial dysfunctions linked to interrupted molecular and functional mechanisms, and discusses CD146’s involvement in angiogenesis and pathological processes in endometrium.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The human endometrium, the innermost lining of the uterus, is the anatomic prerequisite for pregnancy. It is the only dynamic tissue that undergoes more than 400 cycles of regeneration throughout the reproductive life of women. Key to this function are endometrial stem cells as well as cell adhesion molecules. Melanoma cell adhesion molecule (MCAM/CD146/MUC18) is a membrane glycoprotein of the mucin family and a key cell adhesion protein, highly expressed by endometrial cells. CD146 is a significant molecule pivotal in endometrial physiology, assisting tissue regeneration and angiogenesis. Endometrium also acts as a culprit in causing several endometrial dysfunctions, such as endometriosis, endometrial hyperplasia, and endometrial carcinoma, due to interrupted molecular and functional mechanisms. Though most of the endometrial dysfunctions arise as a result of endocrine disturbance, it has a major pathological role associated with angiogenesis. It has already been proven that CD146 is a potential marker for the diagnosis of angiogenic dysfunctions and malignancy, including endometrial cancer. However, its mechanistic role in causing the pathology is a mystery. This chapter explores the role of CD146 in normal and pathological endometrial conditions and the therapeutic implications of CD146.
Full text 26,449 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

The human endometrium, the innermost lining of the uterus, is the anatomic prerequisite for pregnancy. It is the only dynamic tissue that undergoes more than 400 cycles of regeneration throughout the reproductive life of women. Key to this function are endometrial stem cells as well as cell adhesion molecules. Melanoma cell adhesion molecule (MCAM/CD146/MUC18) is a membrane glycoprotein of the mucin family and a key cell adhesion protein, highly expressed by endometrial cells. CD146 is a significant molecule pivotal in endometrial physiology, assisting tissue regeneration and angiogenesis. Endometrium also acts as a culprit in causing several endometrial dysfunctions, such as endometriosis, endometrial hyperplasia, and endometrial carcinoma, due to interrupted molecular and functional mechanisms. Though most of the endometrial dysfunctions arise as a result of endocrine disturbance, it has a major pathological role associated with angiogenesis. It has already been proven that CD146 is a potential marker for the diagnosis of angiogenic dysfunctions and malignancy, including endometrial cancer. However, its mechanistic role in causing the pathology is a mystery. This chapter explores the role of CD146 in normal and pathological endometrial conditions and the therapeutic implications of CD146. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others Abbreviations - AA4: - Anti-CD146 monoclonal antibody clone - AA98: - Anti-CD146 monoclonal antibody clone - AKT-mTOR: - Protein kinase B (Akt)/mammalian target of rapamycin (mTOR) - ALCAM: - Activated leukocyte cell adhesion molecule - a-SMA: - α-smooth muscle actin - CAMs: - Cell adhesion molecules - C-CAM: - Cell-CAM - CCL20: - Chemokine (C-C motif) ligand 20 - CD146: - Cluster of differentiation 146 - CSF: - Cerebrospinal fluid - EC: - Endometrial carcinoma - ECM: - Extracellular matrix - EH: - Endometrial hyperplasia - EMT: - Epithelial-mesenchymal transition - ERK: - Extracellular signal–regulated kinase - ETTs: - Epithelioid trophoblastic tumors - FSH: - Follicle-stimulating hormone - Gab1: - Growth-factor receptor–bound protein 2–associated protein - Gai 1/3: - Gelectin 3 - HUVECs: - Human umbilical vein endothelial cells - ICAM-1: - Intercellular adhesion molecule-1 - IgSF: - Immunoglobulin superfamily - IL10: - Interleukin 10 - IUD: - Intrauterine device - JAK1: - Janus kinase 1 - kDa: - Kilodalton - Ki-67: - Antigen Kiel 67 - lg CD146: - CD146 long isoform - LH: - Luteinizing hormone - M2J-1: - Neutralizing monoclonal antibody - mAb: - Monoclonal antibody - MCAM: - Melanoma cell adhesion molecule - MDA-MB-231: - Human breast cancer cell line - MET-CAM: - Metastasis cell adhesion molecule - MSC: - Mesenchymal stem cells - N-CAM: - Neural cell adhesion molecule - NFKB: - Nuclear factor kappa B - NG2: - Neuron glia antigen-2 - NR4A3: - Nuclear receptor subfamily 4 group A member 3 - P53: - Tumor protein 53 - PCOS: - Polycystic ovarian syndrome - PDGFR β: - Platelet-derived growth factor receptor beta - PSD95: - Drosophila disc large tumor suppressor - PSD95: - Postsynaptic density protein - sCD146: - Soluble CD146 - sh CD146: - CD146 short isoform - STAT3: - Signal transducer and activator of transcription 3 - TNBC: - Triple-negative breast cancer - VEGF: - Vascular endothelial growth factor - WHO: - World Health Organization - Wnt/beta: - Wingless-related integration site beta - Zo-1: - Zonula occludens-1 protein

References

Aldovini D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S, Zeni B, Griso C, Pegoraro C, Zannoni M, Gariboldi M (2006) M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer 119(8):1920–1926 Aplin JD, Kimber SJ (2004) Trophoblast-uterine interactions at implantation. Reprod Biol Endocrinol 2:1–2 Bardin N, Anfosso F, Massé JM, Cramer E, Sabatier F, Bivic AL, Sampol J, Dignat-George F (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood J Am Soc Hematol 98(13):3677–3684 Bikorimana JP, Saad W, Abusarah J, Lahrichi M, Talbot S, Shammaa R, Rafei M (2022) CD146 defines a mesenchymal stromal cell subpopulation with enhanced suppressive properties. Cells 11(15):2263 Black JD, English DP, Roque DM, Santin AD (2014) Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer. Womens Health 10(1):45–57 Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, Durlik M, Pączek L (2006) High rate of endometrial hyperplasia in renal transplanted women. In Transplantation proceedings, vol 38, no 1. Elsevier, pp 177–179 Bouvier S, Kaspi E, Joshkon A, Paulmyer-Lacroix O, Piercecchi-Marti MD, Sharma A, Leroyer AS, Bertaud A, Gris JC, Dignat-George F, Blot-Chabaud M (2021) The role of the adhesion receptor CD146 and its soluble form in human embryo implantation and pregnancy. Front Immunol 26(12):711394 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424 Chabbert-Buffet N, Bouchard P (2002) The normal human menstrual cycle. Rev Endocr Metab Disord 3:173–183 Chaudhari-Kank MS, Zaveri K, Antia V, Hinduja I (2018) Comparison of CD9 & CD146 markers in endometrial stromal cells of fertile & infertile females. Indian J Med Res 147(6):552–559 Chen J, Xu Q, Liu D, Li X, Guo M, Chen X, Liao J, Lei R, Li W, Huang H, Saw PE (2023) CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway. Cancer Commun 43(11):1244–1266 Cousins FL, Gargett CE (2018) Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 1(50):27–38 Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301–313 Critchley HO, Maybin JA, Armstrong GM, Williams AR (2020) Physiology of the endometrium and regulation of menstruation. Physiol Rev. https://doi.org/10.1152/physrev.00031.2019 El-Asrar AM, Nawaz MI, Ahmad A, Siddiquei MM, Allegaert E, Gikandi PW, De Hertogh G, Opdenakker G (2021) CD146/soluble CD146 pathway is a novel biomarker of angiogenesis and inflammation in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 62(9):32 Farland LV, Shah DK, Kvaskoff M, Zondervan KT, Missmer SA (2017) Epidemiological and clinical risk factors for endometriosis. In: Biomarkers for endometriosis: state of the art, pp 95–121 Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, Linkov F (2010) Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21:1851–1856 Feng Y, Ma X, Deng L, Yao B, Xiong Y, Wu Y, Wang L, Ma Q, Ma F (2017) Role of selectins and their ligands in human implantation stage. Glycobiology 27(5):385–391 Fritzsche FR, Wassermann K, Rabien A, Schicktanz H, Dankof A, Loening SA, Dietel M, Jung K, Kristiansen G (2008) CD146 protein in prostate cancer: revisited with two different antibodies. Pathology 40(5):457–464 Fujiwara H, Tatsumi K, Kosaka K, Sato Y, Higuchi T, Yoshioka S, Maeda M, Ueda M, Fujii S (2003) Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166). J Clin Endocrinol Metabol 88(7):3437–3443 Gallos ID, Shehmar M, Thangaratinam S, Papapostolou TK, Coomarasamy A, Gupta JK (2010) Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 203(6):547–5e1 Gargett CE, Gurung S (2016) Endometrial mesenchymal stem/stromal cells, their fibroblast progeny in endometriosis, and more. Biol Reprod 94(6):129 Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15–23 Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A (2006) Expression of the fibrinolytic components in endometriosis. Pathophysiol Haemost Thromb 35(1–2):136–140 Guezguez B, Vigneron P, Alais S, Jaffredo T, Gavard J, Mège RM, Dunon D (2006) A dileucine motif targets MCAM-l cell adhesion molecule to the basolateral membrane in MDCK cells. FEBS Lett 580(15):3649–3656 Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84(3):345–357 Harhouri K, Kebir A, Guillet B, Foucault-Bertaud A, Voytenko S, Piercecchi-Marti MD, Berenguer C, Lamy E, Vely F, Pisano P, Ouafik LH (2010) Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood J Am Soc Hematol 115(18):3843–3851 Heim X, Joshkon A, Bermudez J, Bachelier R, Dubrou C, Boucraut J, Foucault-Bertaud A, Leroyer AS, Dignat-George F, Blot-Chabaud M, Bardin N (2020) CD146/sCD146 in the pathogenesis and monitoring of angiogenic and inflammatory diseases. Biomedicines 8(12):592 Hong IS (2024) Endometrial stem cells: orchestrating dynamic regeneration of endometrium and their implications in diverse endometrial disorders. Int J Biol Sci 20(3):864 Huang Q, He Y, Cao X, Yi C (2020) PTEN and CD146 expression in endometrioid adenocarcinoma. Eur J Gynaecol Oncol 41(3):439–443 Jiang G, Zhang L, Zhu Q, Bai D, Zhang C, Wang X (2016) CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res 35:1–2 Joshkon A, Heim X, Dubrou C, Bachelier R, Traboulsi W, Stalin J, Fayyad-Kazan H, Badran B, Foucault-Bertaud A, Leroyer AS, Bardin N (2020) Role of CD146 (MCAM) in physiological and pathological angiogenesis—contribution of new antibodies for therapy. Biomedicines 8(12):633 Jouve N, Bachelier R, Despoix N, Blin MG, Matinzadeh MK, Poitevin S, Aurrand-Lions M, Fallague K, Bardin N, Blot-Chabaud M, Vely F (2015) CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation. Int J Cancer 137(1):50–60 Kang Y, Wang F, Feng J, Yang D, Yang X, Yan X (2006) Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res 16(3):313–318 Kebir A, Harhouri K, Guillet B, Liu JW, Foucault-Bertaud A, Lamy E, Kaspi E, Elganfoud N, Vely F, Sabatier F, Sampol J (2010) CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo. Circ Res 107(1):66–75 Kikalishvili N, Beriashvili R, Muzashvili T, Burkadze G (2018) Specificities of endometrial proliferation/stem cell index distribution in endometrioid carcinoma of different grade of malignancy. Georgian Med News 1(276):117–123 Kralickova M, Vetvicka V (2016) Role of angiogenesis in endometriosis. Pathol Discov 4(1):1–5 Kumar A, Khurana U, Chowdhary R, Halder A, Kapoor N (2024) Evaluation of the diagnostic utility of MCAM-1 (CD146) in a group of common gynecological cancers: a case-control study. Turkish J Obstet Gynecol 21(1):43 Kunimatsu R, Rikitake K, Yoshimi Y, Putranti NA, Hayashi Y, Tanimoto K (2023) Bone differentiation ability of CD146-positive stem cells from human exfoliated deciduous teeth. Int J Mol Sci 24(4):4048 Kuske MD, Johnson JP (1999) Assignment [sup 1] of the human melanoma cell adhesion molecule gene (MCAM) to chromosome 11 band q23. 3 by radiation hybrid mapping. Cytogenetics & Cell Genetics 87(3–4):258 Lee Y, Kim KR, McKeon F, Yang A, Boyd TK, Crum CP, Parast MM (2007) A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol 38(7):1003–1013 Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmüller G, Johnson JP (1987a) Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47(3):841–845 Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmüller G, Johnson JP (1987b) Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47(3):841–845 Lehmann JM, Riethmüller G, Johnson JP (1989) MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci 86(24):9891–9895 Lei X, Guan CW, Song Y, Wang H (2015) The multifaceted role of CD146/MCAM in the promotion of melanoma progression. Cancer Cell Int 15:1–1 Leñero C, Kaplan LD, Best TM, Kouroupis D (2022) CD146+ endometrial-derived mesenchymal stem/stromal cell subpopulation possesses exosomal secretomes with strong immunomodulatory miRNA attributes. Cells 11(24):4002 Lessey BA (1998) Endometrial integrins and the establishment of uterine receptivity. Hum Reprod 13(Suppl_3):247–258 Li W, Yang D, Wang S, Guo X, Lang R, Fan Y, Gu F, Zhang X, Niu Y, Yan X, Fu L (2011a) Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: comparative study with invasive ductal carcinoma-not otherwise specified. Pathol Res Pract 207(12):739–746 Li J, Shi Y, Wan X, Qian H, Zhou C, Chen X (2011b) Epithelioid trophoblastic tumor: a clinicopathological and immunohistochemical study of seven cases. Med Oncol 28:294–299 Li Y, Chai JL, Shi X, Feng Y, Li JJ, Zhou LN, Cao C, Li KR (2023) Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis. Theranostics 13(7):2319 Liang Y, Voshart D, Paridaen JT, Oosterhof N, Liang D, Thiruvalluvan A, Zuhorn IS, den Dunnen WF, Zhang G, Lin H, Barazzuol L (2022) CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling. Cell Mol Life Sci 79(8):398 Liao J, Fu Q, Chen W, Li J, Zhang W, Zhang H, Gao Y, Yang S, Xu B, Huang H, Wang J (2020) Plasma soluble CD146 as a potential diagnostic marker of acute rejection in kidney transplantation. Front Med 25(7):531999 Liu Q, Yan X, Li Y, Zhang Y, Zhao X, Shen Y (2004) Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblast. Lab Investig 84(2):221–228 Liu Q, Zhang B, Zhao X, Zhang Y, Liu Y, Yan X (2008) Blockade of adhesion molecule CD146 causes pregnancy failure in mice. J Cell Physiol 215(3):621–626 Liu WF, Ji SR, Sun JJ, Zhang Y, Liu ZY, Liang AB, Zeng HZ (2012) CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer. Int J Mol Sci 13(5):6399–6406 Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, Ma N (2019) Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci 1(76):1681–1695 Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M (1993) Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 3(1):35–41 Lv Z, Feng HY, Tao W, Li HZ, Zhang X (2021) CD146 as a prognostic-related biomarker in ccRCC correlating with immune infiltrates. Front Oncol 11:744107 Mannion AJ, Odell AF, Baker SM, Matthews LC, Jones PF, Cook GP (2023) Pro-and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition. Front Cell Dev Biol 11:1129015 Marečková M, Garcia-Alonso L, Moullet M, Lorenzi V, Petryszak R, Sancho-Serra C, Oszlanczi A, Mazzeo CI, Hoffman S, Krassowski M, Garbutt K (2023) An integrated single-cell reference atlas of the human endometrium. bioRxiv 11. https://doi.org/10.1101/2023.11.03.564728 Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M (2002) Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res 62(17):5106–5114 Montgomery BE, Daum GS, Dunton CJ (2004) Endometrial hyperplasia: a review. Obstet Gynecol Surv 59(5):368–378 Murray MJ, Zhang J, Lessey BA (1999) Expression of α6 and β4 integrin subunits throughout the menstrual cycle: no correlation with uterine receptivity. Fertil Steril 72(3):522–526 Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M (2022) Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet 1:1–5 Neve A, Cantatore FP, Maruotti N, Corrado A, Ribatti D (2014) Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed Res Int 2014(1):756078 Obu S, Umeda K, Ueno H, Sonoda M, Tasaka K, Ogata H, Kouzuki K, Nodomi S, Saida S, Kato I, Hiramatsu H (2021) CD146 is a potential immunotarget for neuroblastoma. Cancer Sci 112(11):4617–4626 Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA, Suda T (2001) ALCAM (CD166): its role in hematopoietic and endothelial development. Blood J Am Soc Hematol 98(7):2134–2142 Olajuyin AM, Olajuyin AK, Wang Z, Zhao X, Zhang X (2019) CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target. Cancer Cell Int 19(1):247 Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F, Takeichi M (1994) A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54(23):6282–6287 Parasar P, Ozcan P, Terry KL (2017) Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 6:34–41 Ribatti D, Nico B, Crivellato E (2011) The role of pericytes in angiogenesis. Int J Dev Biol 55(3):261–268 Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT (2017) New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update 23(2):232–254 Sers C, Kirsch K, Rothbächer U, Riethmüller G, Johnson JP (1993) Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci 90(18):8514–8518 Shamosi A, Farokhi M, Ai J, Sharifi E (2015) Induction of spontaneous neo-angiogenesis and tube formation in human endometrial stem cells by bioglass. J Med Hypotheses Ideas 9(2):94–98 Sharma A, Joshkon A, Ladjimi A, Traboulsi W, Bachelier R, Robert S, Foucault-Bertaud A, Leroyer AS, Bardin N, Somasundaram I, Blot-Chabaud M (2022) Soluble CD146 as a potential target for preventing triple negative breast cancer MDA-MB-231 cell growth and dissemination. Int J Mol Sci 23(2):974 Sharma A, Somasundaram I, Chabaud MB (2024) CD146 as a prognostic marker in breast cancer: a meta-analysis. J Cancer Res Ther 20(1):193–198 Shih IM, Wang TL, Wu TC, Kurman RJ, Gearhart JD (1998a) Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci 111(17):2655–2664 Shih IM, Wang TL, Wu TC, Kurman RJ, Gearhart JD (1998b) Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci 111(17):2655–2664 So JH, Hong SK, Kim HT, Jung SH, Lee MS, Choi JH, Bae YK, Kudoh T, Kim JH, Kim CH (2010) Gicerin/Cd146 is involved in zebrafish cardiovascular development and tumor angiogenesis. Genes Cells 15(11):1099–1110 Sourial S, Tempest N, Hapangama DK (2014) Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014(1):179515 Stalin J, Harhouri K, Hubert L, Garrigue P, Nollet M, Essaadi A, Muller A, Foucault-Bertaud A, Bachelier R, Sabatier F, Pisano P (2016) Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform. Cardiovasc Res 111(3):240–251 Svalander PC, Odin P, Nilsson BO, Öbrink B (1987) Trophectoderm surface expression of the cell adhesion molecule cell-CAM 105 on rat blastocysts. Development 100(4):653–660 Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19(6):771–783 Taira E, Nagino T, Tsukamoto Y, Okumura S, Muraoka O, Sakuma F, Miki N (1999) Cytoplasmic domain is not essential for the cell adhesion activities of gicerin, an Ig-superfamily molecule. Exp Cell Res 253(2):697–703 Taira E, Kohama K, Tsukamoto Y, Okumura S, Miki N (2004) Characterization of Gicerin/MUC18/CD146 in the rat nervous system. J Cell Physiol 198(3):377–387 Taira E, Kohama K, Tsukamoto Y, Okumura S, Miki N (2005) Gicerin/CD146 is involved in neurite extension of NGF-treated PC12 cells. J Cell Physiol 204(2):632–637 Thomson AJ, Greer MR, Young A, Boswell F, Telfer JF, Cameron IT, Norman JE, Campbell S (1999) Expression of intercellular adhesion molecules ICAM-1 and ICAM-2 in human endometrium: regulation by interferon-γ. Mol Hum Reprod 5(1):64–70 Tran AN, Kim HY, Oh SY, Kim HS (2023) CD49f and CD146: a possible crosstalk modulates Adipogenic differentiation potential of mesenchymal stem cells. Cells 13(1):55 Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA (2008) Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 40(8):673–679 van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, Bloemers HP, Figdor CG, Swart GW (2001) Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276(28):25783–25790 Wang Z, Yan X (2013) CD146, a multi-functional molecule beyond adhesion. Cancer Lett 330(2):150–162 Wang B, Sheng JZ, He RH, Qian YL, Jin F, Huang HF (2008a) High expression of l-selectin ligand in secretory endometrium is associated with better endometrial receptivity and facilitates embryo implantation in human being. Am J Reprod Immunol 60(2):127–134 Wang HB, Xuan DU, Xu YH, Wang ZH (2008b) Identification of CD146 expression in human and mouse preimplantation embryo. J Reprod Contracept 19(1):17–26 Wang G, Tokushige N, Markham R, Fraser IS (2009) Rich innervation of deep infiltrating endometriosis. Hum Reprod 24(4):827–834 Wang P, Luo Y, Duan H, Xing S, Zhang J, Lu D, Feng J, Yang D, Song L, Yan X (2013) MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol 33(18):3689–3699 Wang D, Duan H, Feng J, Xiang J, Feng L, Liu D, Chen X, Jing L, Liu Z, Zhang D, Hao H (2020) Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction. Theranostics 10(1):231 Wang YH, Li CX, Stephenson JM, Marrelli SP, Kou YM, Meng DZ, Wu T (2021) NR4A3 and CCL20 clusters dominate the genetic networks in CD146+ blood cells during acute myocardial infarction in humans. Eur J Med Res 26:1–5 Wang J, Wu Z, Zheng M, Yu S, Zhang X, Xu X (2022) CD146 is closely associated with the prognosis and molecular features of osteosarcoma: guidance for personalized clinical treatment. Front Genet 21(13):1025306 Wu GJ, Dickerson EB (2014) Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma. Taiwan J Obstet Gynecol 53(4):509–517 Wu GJ, Wu MW, Wang C, Liu Y (2011) Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice. J Urol 185(4):1504–1512 Xue B, Wang P, Yu W, Feng J, Li J, Zhao R, Yang Z, Yan X, Duan H (2022) CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases. Sci China Life Sci 65(6):1157–1170 Yan X, Lin Y, Yang D, Shen Y, Yuan M, Zhang Z, Li P, Xia H, Li L, Luo D, Liu Q (2003) A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102(1):184–191 Yang Y, Zhu L, Yao C, Li Y, Chen L, Ye W, Zhang C (2022) Study of the mechanism by which Sp1/CD146 induces UCA-PSCs angiogenesis through the WNT/β-catenin pathway. Research Square. Yang Q, Huang W, Hsu JC, Song L, Sun X, Li C, Cai W, Kang L (2023) CD146-targeted nuclear medicine imaging in cancer: state of the art. Viewpoints 4(5):20220085 Yu Z, Zhang Q, Wei S, Zhang Y, Zhou T, Zhang Q, Shi R, Zinovkin D, Pranjol ZI, Zhang J, Wang H (2024) CD146+ CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10/JAK1/STAT3 pathway. Cell Commun Signaling 22(1):170 Yüksel H, Zafer E (2020) Endometrial stem/progenitor cells. Curr Obstet Gynecol Rep 9:7–14 Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C (2009) CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res 11:1–4 Zhang H, Zhang J, Wang Z, Lu D, Feng J, Yang D, Chen X, Yan X (2013) CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer. Oncol Lett 5(4):1189–1194 Zhang X, Wang Z, Kang Y, Li X, Ma X, Ma L (2014) MCAM expression is associated with poor prognosis in non-small cell lung cancer. Clin Transl Oncol 16:178–183 Zhang ZY, Zhai C, Yang XY, Li HB, Wu LL, Li L (2022) Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway. PLoS One 17(8):e0273542 Zhang L, Zhang X, Liu Y, Zhang W, Wu CT, Wang L (2023) CD146+ umbilical cord mesenchymal stem cells exhibit high immunomodulatory activity and therapeutic efficacy in septic mice. J Inflamm Res 31:579–594 Zhou Y, Huang H, Yuan LJ, Xiong Y, Huang X, Lin JX, Zheng M (2015) CD146 as an adverse prognostic factor in uterine sarcoma. Eur J Med Res 20:1–8 Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Hilage, P., Damle, M.N., Sharma, R.K., Joshi, M.G. (2024). Melanoma Cell Adhesion Molecule (CD 146) in Endometrial Physiology and Disorder. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 23. Advances in Experimental Medicine and Biology(), vol 1474. Springer, Cham. https://doi.org/10.1007/5584_2024_826 Download citation DOI: https://doi.org/10.1007/5584_2024_826 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-83688-6 Online ISBN: 978-3-031-83689-3 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen CD146 Antigen

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-17T06:13:18.893374+00:00
pubmed
last seen: 2026-06-17T06:10:48.189925+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine